Fibromodulin, an extracellular matrix protein: Characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

Blood

Volumn 105, Issue 12, 2005, Pages 4828-4835

  Mikaelsson, Eva ^b   Danesh Manesh, Amir Hossein ^b   Lüppert, Alfred ^b   Jeddi Tehrani, Mahmood ^b   Rezvany, Mohammad Reza ^b   Sharifian, Ramazan Ali ^b   Safaie, Reza ^b   Roohi, Azam ^b   Österborg, Anders ^b   Shokri, Fazel ^b   Mellstedt, Håkan ^a   Rabbani, Hodjattallah ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROMODULIN; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; SCLEROPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL LINE; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOPLASM; FEMALE; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE MUTATION; GRANULOCYTE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; T LYMPHOCYTE;

EID: 20444406861     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-10-3941     Document Type: Article

References (58)

1. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625-1638.
2. Jelinek DF, Tschumper RC, Stolovitzky GA, et al. Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res. 2003;1:346-361.
3. Wierda WG, Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol. 1999;6:253-261.
4. Stilgenbauer S, Bullinger L, Lichter P, Dohner H. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia. 2002;16:993-1007.
5. Ghia P, Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res. 2000;79:157-173.
6. Lagneaux L, Delforge A, Bran D, De Bruyn C, Stryckmans P. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow siromal cells. Blood. 1998;91:2387-2396.
7. Jewell AP, Yong KL. Regulation and function of adhesion molecules in B-cell chronic lymphocytic leukaemia. Acta Haematol. 1997;97:67-72.
8. de la Fuente MT, Casanova B, Garcia-Gila M, Silva A, Garcia-Pardo A. Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. Leukemia. 1999;13:266-274.
9. Caligaris-Cappio F. Role of the microenvironment in chronic lymphocytic leukaemia. Br J Haematol. 2003;123:380-388.
10. Oldberg A, Antonsson P, Lindblom K, Heinegard D. A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J. 1989;8:2601-2604.
11. Svensson L, Narlid I, Oldberg A. Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett. 2000;470:178-182.
12. Hildebrand A, Romaris M, Rasmussen LM, et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J. 1994;302(pt 2):527-534.
13. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346:281-284.
14. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest. 1998;101:406-412.
15. Schonherr E, Levkau B, Schaefer L, Kresse H, Walsh K. Decorin affects endothelial cells by Akt-dependent and -independent pathways. Ann N Y Acad Sci. 2002;973:149-152.
16. Onnerfjord P, Heathfield TF, Heinegard D. Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry. J Biol Chem. 2004;279:26-33.
17. Mikaelsson E, Jeddi-Tehrani M, Osterborg A, Shokri F, Mellstedt H, Rabbani H. Fibromodulin-a novel tumor associated antigen exclusively expressed in tumor B-cells from patients with chronic lymphocytic leukemia and mantle cell lymphoma [abstract]. Leuk Lymphoma. 2003;44:21.
18. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol J. 2000;1:53-66.
19. Moazzeni M, Mosayyebi G, Stevenson FK, Abbot S, Mageed RA, Shokri F. Biased utilization of immunoglobulin variable region heavy- and light-chain genes by the malignanl CD5- B lymphocytes from patients with Burkitt's lymphoma. Int J Cancer. 1994;58:226-232.
20. Cardoen S, Van Den Neste E, Smal C, et al. Resistance to 2-chloro-2′-deoxyadenosine of the human B-cell leukemia cell line EHEB. Clin Cancer Res. 2001;7:3559-3566.
21. Carlsson M, Soderberg O, Nilsson K. Interleukin-4 (IL-4) enhances homotypic adhesion of activated B-chronic lymphocytic leukaemia (B-CLL) cells via a selective up-regulation of CD54. Scand J Immunol. 1993;37:515-522.
22. Rezvany MR, Jeddi-Tehrani M, Rabbani H, et al. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. Br J Haematol. 2000;111:608-617.
23. Shokri F, Mageed RA, Maziak BR, Jefferis R. Expression of VHIII-associated cross-reactive idiotype on human B lymphocytes: association with staphylococcal protein A binding and Staphylococcus aureus Cowan I stimulation. J Immunol. 1991;146:936-940.
24. Roughley PJ, White RJ, Cs-Szabo G, Mort JS. Changes with age in the structure of fibromodulin in human articular cartilage. Osteoarthritis Cartilage. 1996;4:153-161.
25. Heinegard D, Larsson T, Sommarin Y, Franzen A, Paulsson M, Hedbom E. Two novel matrix proteins isolated from articular cartilage show wide distributions among connective tissues. J Biol Chem. 1986;261:13866-13872.
26. Goldenberger D, Perschil I, Ritzler M, Altwegg M. A simple "universal" DNA extraction procedure using SDS and proteinase K is compatible with direct PCR amplification. PCR Methods Appl. 1995;4:368-370.
27. Stilgenbauer S, Lichter P, Dohner H. Genetic features of B-cell chronic lymphocytic leukemia. Rev Clin Exp Hematol. 2000;4:48-72.
28. Cavazzini F, Cuneo A, de Angeli C, et al. Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia. Leuk Lymphoma. 2004;45:1197-1203.
29. Fukuda T, Lu D, Carson DA, Kipps TJ. Restricted expression of the orphan tyrosine kinase receptor ROR1 in chronic lymphocytic leukemia [abstract]. Blood. 2004;104:772.
30. Lopez-Matas M, Rodriguez-Justo M, Morilla R, Catovsky D, Matutes E. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Haematologica. 2000;85:1140-1145.
31. Sjoberg J, Aguilar-Santelises M, Sjogren AM, et al. Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease. Br J Haematol. 1996;92:393-400.
32. Saamanen AM, Salminen HJ, Rantakokko AJ, Heinegard D, Vuorio EI. Murine fibromodulin: cDNA and genomic structure, and age-related expression and distribution in the knee joint. Biochem J. 2001;355:577-585.
33. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 2002;16:673-680.
34. Jepsen KJ, Wu F, Peragallo JH, et al. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem. 2002;277:35532-35540.
35. Hao X, Sun B, Hu L, et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004;100:1110-1122.
36. Tchernitsa OI, Sers C, Zuber J, et al. Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene. 2004;23:4536-4555.
37. Urs S, Smith C, Campbell B, et al. Gene expression profiling in human preadipocytes and adipocytes by microarray analysis. J Nutr. 2004;134:762-770.
38. Han Z, Ni J, Smits P, et al. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J. 2001;15:988-994.
39. Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem. 2003;278:17491-17499.
40. Seidel C, Borset M, Hjertner O, et al. High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity. Blood. 2000;96:3139-3146.
41. Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP. Leukocyte, ratherthan tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med. 2003;198:1475-1485.
42. Wilkins PP, Moore KL, McEver RP, Cummings RD. Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J Biol Chem. 1995;270:22677-22680.
43. Salih E. In vivo and in vitro phosphorylation regions of bone sialoprotein. Connect Tissue Res. 2003;44(suppl 1):223-229.
44. Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol. 1996;92:97-103.
45. Douglas RS, Capocasale RJ, Lamb RJ, Nowell PC, Moore JS. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta. Blood. 1997;89:941-947.
46. DeCoteau JF, Knaus PI, Yankelev H, et al. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1997;94:5877-5881.
47. Friedenberg WR, Salzman SA, Phan SM, Burmester JK. Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia. Med Oncol. 1999;16:110-118.
48. Schuler M, Treuer T, Schneller F, Huber C, Peschel C. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals. Immunobiology. 1999;200:128-139.
49. Lindschau C, Quass P, Menne J, et al. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Hypertension. 2003;42:335-341.
50. Templeton DM, Liu Y. Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta. 2003;1619:113-124.
51. Alcantara O, Kalidas M, Baltathakis I, Boldt DH. Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron. Exp Hematol. 2001;29:1060-1069.
52. Habel ME, Lemieux R, Jung D. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression. J Cell Physiol. 2005;203:277-285.
53. Gazitt Y, Reddy SV, Alcantara O, Yang J, Boldt DH. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. J Cell Physiol. 2001;187:124-135.
54. Alcantara O, Obeid L, Hannun Y, Ponka P, Boldt DH. Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-beta and PKC-alpha gene expression and role of the 5′-flanking region of the PKC-beta gene in the response to ferric transferrin. Blood. 1994;84:3510-3517.
55. Parkes JG, Liu Y, Sima JB, Templeton DM. Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. J Mol Cell Cardiol. 2000;32:233-246.
56. Lai JM, Wu S, Huang DY, Chang ZF. Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21(Cip1/Waf1) in phorbol 12-myristate-13-acetate- induced apoptotic cells. Mol Cell Biol. 2002;22:7581-7592.
57. Dono M, Zupo S, Colombo M, et al. The human marginal zone B cell. Ann N Y Acad Sci. 2003;987:117-124.
58. Mayr C, Bund D, Schlee M, et al. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. Blood. 2005;105:1566-1573.